| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |